Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism

Psychopharmacology

Volumn 193, Issue 4, 2007, Pages 547-555

  Schneider, Tomasz ^a,b   Ziòłkowska, Barbara ^a   Gieryk, Agnieszka ^a   Tyminska, Anna ^a   Przewłocki, Ryszard ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Animal model; Autism; Enkephalins; Opioids; Valproic acid

Indexed keywords

MESSENGER RNA; NALOXONE; OPIATE PEPTIDE; PROENKEPHALIN; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTISM; AVERSIVE BEHAVIOR; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; DOPAMINERGIC SYSTEM; EMOTION; FEMALE; GABAERGIC SYSTEM; GENE EXPRESSION; IN SITU HYBRIDIZATION; LEARNING; MAZE TEST; MEMORY; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEUS ACCUMBENS; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICONVULSANTS; ANXIETY; AUTISTIC DISORDER; BASAL GANGLIA; CONDITIONING, CLASSICAL; DISEASE MODELS, ANIMAL; DOPAMINE; EMOTIONS; ENKEPHALINS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; LEARNING; MALE; MAZE LEARNING; MEMORY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); RNA, MESSENGER; VALPROIC ACID;

EID: 34447626496     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0795-y     Document Type: Article

References (82)

1. Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM (1984) Endogenous opioids: biology and function. Annu Rev Neurosci 7:223-255
2. Akil H, Owens C, Gutstein H, Taylor L, Curran E, Watson S (1998) Endogenous opioids: overview and current issues. Drug Alcohol Depend 51:127-140
3. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th edn.). Washington, DC, pp 66-71
4. Angulo JA (1992) Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. J Neurochem 58:1104-1109
5. Bauman ML, Kemper TL (1994) Neuroanatomic observation of the brain in autism. In: Bauman ML, Kemper TL (eds) The neurobiology of autism. John Hopkins Univ. Press, Baltimore, pp 119-145
6. Belzung C (1992) Hippocampal mossy fibres: implication in novelty reactions or in anxiety behaviours? Behav Brain Res 51:149-155
7. Bilkei-Gorzo A, Racz I, Michel K, Zimmer A, Klingmuller D, Zimmer A (2004) Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology (Berl) 176:343-352
8. Chen JF, Aloyo VJ, Weiss B (1993) Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience 54:669-680
9. Courchesne E (1997) Brain stem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr Opin Neurobiol 7:269-278
10. da Silva Torres IL, Cucco SN, Bassani M, Duarte MS, Silveira PP, Vasconcellos AP, Tabajara AS, Dantas G, Fontella FU, Dalmaz C, Ferreira MB (2003) Long-lasting delayed hyperalgesia after chronic restraint stress in rats-effect of morphine administration. Neurosci Res 45:277-283
11. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, Carboni E (1999) Drug addiction as a disorder of associative learning Role of nucleus accumbens shell/extended amygdala dopamine. Ann NY Acad Sci 877:461-485
12. Drolet G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF (2001) Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25:729-741
13. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats 1: behavioral data. Behav Brain Res 31:47-59
14. Ennaceur A, Meliani K (1992) A new one-trial test for neurobiological studies of memory in rats 3: spatial vs non-spatial working memory. Behav Brain Res 51:83-92
15. File SE (1993) The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58:199-202
16. File SE, Hyde JR (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19-24
17. File SE, Zangrossi H Jr, Viana M, Graeff FG (1993) Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology (Berl) 111:491-494
18. Frith U, Happe F (2005) Autism spectrum disorder. Curr Biol 15:786-790
19. Gaffney GR, Kuperman S, Tsai LY, Minchin S (1988) Morphological evidence for brainstem involvement in infantile autism. Biol Psychiatry 24:578-586
20. Ghaziuddin M, Ghaziuddin N, Greden J (2002) Depression in persons with autism: implications for research and clinical care. J Autism Dev Disord 32:299-306
21. Good AJ, Westbrook RF (1995) Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats. Behav Neurosci 109:631-641
22. Grevert P, Goldstein A (1977) Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects. Proc Natl Acad Sci USA 74:1291-1294
23. Hablitz JJ, Tehrani MH, Barnes EM Jr. (1989) Chronic exposure of developing cortical neurons to GABA down-regulates GABA/benzodiazepine receptors and GABA-gated chloride currents. Brain Res 501:332-338
24. Haller J, Bakos N (2002) Stress-induced social avoidance: a new model of stress-induced anxiety? Physiol Behav 77:327-332
25. Haller J, Leveleki C, Baranyi J, Mikics E, Bakos N (2003) Stress, social avoidance and anxiolytics: a potential model of stress-induced anxiety. Behav Pharmacol 14:439-446
26. Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, Kuroda Y (1995) Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord 25:1-18
27. Hollister LE, Johnson K, Boukhabza D, Gillespie HK (1981) Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depend 8:37-41
28. Ikemoto S, Kohl RR, McBride WJ (1997) GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J Neurochem 69:137-143
29. Ingram JL, Peckham M, Tisdale B, Rodier PM (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 22:319-324
30. Ishizaki T, Yokochi K, Chiba K, Tabuchi T, Wagatsuma T (1981) Placental transfer of anticonvulsants (phenobarbital, phenytoin, valproic acid) and the elimination from neonates. Pediatr Pharmacol (New York) 1:291-303
31. Kalat JW (1978) Speculations of similarities between autism and opiate addiction. J Autism Child Schizophrenia 8:477-479
32. King CD, Devine DP, Vierck CJ, Rodgers J, Yezierski RP (2003) Differential effects of stress on escape and reflex responses to nociceptive thermal stimuli in the rat. Brain Res 987:214-222
33. Knott PJ, Hutson PH (1982) Stress-induced stereotypy in the rat: neuropharmacological similarities to Tourette syndrome. Adv Neurol 35:233-238
34. Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A (1996) Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383:535-538
35. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129
36. Kowalski C, Giraud P (1993) Dopamine decreases striatal enkephalin turnover and proenkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures. Neuroscience 53:665-672
37. LeDoux JE (2000) Emotion circuits in the brain. Annu Rev Neurosci 23:155-184
38. Levine S (1962) Plasma-free corticosteroid response to electric shock in rats stimulated in infancy. Science 9:795-796
39. Levine S (1967) Maternal and environmental influences on the adrenocortical response to stress in weanling rats. Science 156:258-260
40. Liu J, Morrow AL, Devaud L, Grayson DR, Lauder JM (1997) GABAA receptors mediate trophic effects of GABA on embryonic brainstem monoamine neurons in vitro. J Neurosci 17:2420-2428
41. Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267:495-499
42. Martin del Campo AF, McMurray RG, Besser GM, Grossman A (1992) Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers. Biol Psychiatry 32:344-353
43. McGaugh JL, Cahill L, Roozendaal B (1996) Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci USA 93:13508-13514
44. Mesdjian E, Ciesielski L, Valli M, Bruguerolle B, Jadot G, Bouyard P, Mandel P (1982) Sodium valproate: kinetic profile and effects on GABA levels in various brain areas of the rat. Prog Neuro-psychopharmacol Biol Psychiatry 6:223-233
45. Miyazaki C, Matsuyama K, Ichikawa M, Goto S (1988) Effect of sodium valproate (VPA) on cerebral amino acids: mechanism of gamma-aminobutyric acid (GABA) elevation and possible causal relation of VPA-induced encephalopathy and glutamine level. Chem Pharm Bull (Tokyo) 36:3589-3594
46. Morris BJ, Hollt V, Herz A (1988) Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists. Neuroscience 25:525-532
47. Mucha RF, Millan MJ, Herz A (1985) Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin. Psychopharmacology (Berl) 86:281-285
48. Muris P, Steerneman P, Merckelbach H, Holdrinet I, Meesters C (1998) Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Disord 12:387-393
49. Napier TC, Pirch JH, Strahlendorf HK (1983) Naloxone antagonizes striatally-induced suppression of globus pallidus unit activity. Neuroscience 9:53-59
50. Narayanan S, Lam H, Christian L, Levine MS, Grandy D, Rubinstein M, Maidment NT (2004) Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation. Neuroscience 124:241-246
51. Nau H, Hauck RS, Ehlers K (1991) Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol Toxicol 69:310-321
52. Nieto MM, Guen SL, Kieffer BL, Roques BP, Noble F (2005) Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135:305-313
53. Olson GA, Olson RD, Kastin AJ (1996) Endogenous opiates. Peptides 17:1421-1466
54. Ozonoff S, Goodlin-Jones BL, Solomon M (2005) Evidence-based assessment of autism spectrum disorders in children and adolescents. J Clin Child Adolesc Psychol 34:523-540
55. Palermo-Neto J, de Oliveira Massoco C, Robespierre de Souza W (2003) Effects of physical and psychological stressors on behavior, macrophage activity, and Ehrlich tumor growth. Brain Behav Immun 17:43-54
56. Panksepp J (1979) A neurochemical theory of autism. Trends Neurosci 2:174-177
57. Panksepp J, Herman B, Villberg T (1978) An opiate excess model of childhood autism. Neuroscience 4:500 (Abstract)
58. Parker LA, Rennie M (1992) Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms. Pharmacol Biochem Behav 41:559-565
59. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, Sydney, Australia
60. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
61. Przewlocki R, Lason W, Hollt V, Silberring J, Herz A (1987) The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord. Brain Res 413:213-219
62. Ragnauth A, Schuller A, Morgan M, Chan J, Ogawa S, Pintar J, Bodnar RJ, Pfaff DW (2001) Female preproenkephalin-knockout mice display altered emotional responses. Proc Natl Acad Sci USA 9:1958-1963
63. Robbins TW, Everitt BJ (1996) Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6:228-236
64. Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J (1996) Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 370:247-261
65. Rodier PM, Ingram JL, Tisdale B, Croog VJ (1997) Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 11:417-422
66. Sahley TL, Panksepp J (1987) Brain opioids and autism: an updated analysis of possible linkages. J Autism Dev Disord 17:201-216
67. Saitoh A, Yoshikawa Y, Onodera K, Kamei J (2005) Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats. Psychopharmacology (Berl) 182:327-334
68. Schneider T, Przewlocki R (2005) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30:80-89
69. Schneider T, Turczak J, Przewlocki R (2006) Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 31:36-46
70. Schousboe A, Redburn DA (1995) Modulatory actions of gamma aminobutyric acid (GABA) on GABA type A receptor subunits expression. J Neurosci Res 41:1-7
71. Shattock P, Whiteley P (2002) Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets 6:175-183
72. Shippenberg TS, Bals-Kubik R (1995) Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat. Behav Pharmacol 6:99-106
73. Skoubis PD, Maidment NT (2003) Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat. Neuroscience 119:241-249
74. Skoubis PD, Matthes HW, Walwyn WM, Kieffer BL, Maidment NT (2001) Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice. Neuroscience 106:757-763
75. Skoubis PD, Lam HA, Shoblock J, Narayanan S, Maidment NT (2005) Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice. Eur J Neurosci 21:1379-1384
76. Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773
77. Tehrani MH, Barnes EM Jr. (1988) GABA down-regulates the GABA/benzodiazepine receptor complex in developing cerebral neurons. Neurosci Lett 87:288-292
78. Towbin KE, Pradella A, Gorrindo T, Pine DS, Leibenluft E (2005) Autism spectrum traits in children with mood and anxiety disorders. J Child Adolesc Psychopharmacol 15:452-464
79. Valverde O, Fournie-Zaluski MC, Roques BP, Maldonado R (1996) Similar involvement of several brain areas in the antinociception of endogenous and exogenous opioids. Eur J Pharmacol 312:15-25
80. Vanderschuren LJ, Niesink RJ, Spruijt BM, Van Ree JM (1995) Influence of environmental factors on social play behavior of juvenile rats. Physiol Behav 58:119-123
81. Yoshikawa K, Williams C, Sabol S (1984) Rat brain preproenkephalin mRNA-cDNA cloning, primary structure, and distribution in the central nervous system. J Biol Chem 259:14301-14308
82. Young WS, Bonner TI, Brann MR (1986) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83:9827-9831